Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society · 2025
Subclinical Epileptiform Discharge in Patients With Alzheimer Dementia: A Systematic Review and Meta-Analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yeh Wei-Chih, Yang Yuan-Han, Li Ying-Sheng, Hsu Chung-Yao
Аннотация
PURPOSE: Patients with Alzheimer's dementia (AD) who do not have a history of epilepsy have a higher frequency of subclinical epileptiform discharge (SED) than healthy individuals. This meta-analysis aims to investigate the frequency of SED in patients with AD using different EEG protocols and to compare SED rates between early- and late-onset AD.
METHODS: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. We searched various databases until January 2024 for studies reporting the frequency of SED in patients with AD who did not have a history of epilepsy. A meta-analysis was conducted using a random-effects model.
RESULTS: Thirteen studies involving 1,373 patients with AD were analyzed. The patients had a mean age of 71.2 years, and 59.3% were women. The pooled SED rate was found to be 18.3%. The SED rate was higher with extended EEG protocols (26.7%) than with routine EEG protocols (12.1%). It was also observed that patients with early-onset AD had higher SED rates with routine EEG protocols (14.4%) and extended EEG protocols (43.9%) than those with late-onset AD (10.5 and 21.3%, respectively). Furthermore, patients with AD had a 3.55 relative risk ( P < 0.001) of SED compared with healthy controls. Specifically, patients with early-onset AD showed a significantly higher risk of developing SED than those with late-onset AD (relative risk, 4.48; P < 0.001).
CONCLUSIONS: Subclinical epileptiform discharge frequency was high in patients with AD, particularly in those with early onset AD.
METHODS: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. We searched various databases until January 2024 for studies reporting the frequency of SED in patients with AD who did not have a history of epilepsy. A meta-analysis was conducted using a random-effects model.
RESULTS: Thirteen studies involving 1,373 patients with AD were analyzed. The patients had a mean age of 71.2 years, and 59.3% were women. The pooled SED rate was found to be 18.3%. The SED rate was higher with extended EEG protocols (26.7%) than with routine EEG protocols (12.1%). It was also observed that patients with early-onset AD had higher SED rates with routine EEG protocols (14.4%) and extended EEG protocols (43.9%) than those with late-onset AD (10.5 and 21.3%, respectively). Furthermore, patients with AD had a 3.55 relative risk ( P < 0.001) of SED compared with healthy controls. Specifically, patients with early-onset AD showed a significantly higher risk of developing SED than those with late-onset AD (relative risk, 4.48; P < 0.001).
CONCLUSIONS: Subclinical epileptiform discharge frequency was high in patients with AD, particularly in those with early onset AD.